Page last updated: 2024-10-25

cimetidine and Disease Exacerbation

cimetidine has been researched along with Disease Exacerbation in 7 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research Excerpts

ExcerptRelevanceReference
" The underlying mechanism for TL-118-treatment success was associated with hepatic perfusion attenuation resulting from reduced nitric-oxide (NO) serum levels as elucidated by using hemodynamic response imaging (HRI, a functional MRI combined with hypercapnia and hyperoxia)."1.38Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice. ( Abramovitch, R; Corchia, N; Edrei, Y; Gross, E, 2012)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Longhini, R1
Aparecida de Oliveira, P1
Sasso-Cerri, E1
Cerri, PS1
Tan, HH1
Chang, CY1
Martin, P1
Edrei, Y1
Gross, E1
Corchia, N1
Abramovitch, R1
Nogi, K1
Taniguchi, H1
Onoda, Y1
Kinouchi, T1
Sakamoto, J1
Tsukamoto, T1
Akaza, H1
Kubota, Y1
Ozono, S1
Kanetake, H1
Taguchi, T1
Kotake, T1
Urrea, AA1
VĂ©lez, GM1
Nogues, AE1
Camarasa, JG1
Creagan, ET1
Ahmann, DL1
Frytak, S1
Long, HJ1
Chang, MN1
Itri, LM1

Trials

2 trials available for cimetidine and Disease Exacerbation

ArticleYear
Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.
    Journal of cancer research and clinical oncology, 2006, Volume: 132, Issue:8

    Topics: Adult; Aged; Carcinoma, Renal Cell; Cimetidine; Disease Progression; Drug Therapy, Combination; Fema

2006
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.
    Cancer, 1987, Feb-01, Volume: 59, Issue:3 Suppl

    Topics: Adjuvants, Immunologic; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot

1987

Other Studies

5 other studies available for cimetidine and Disease Exacerbation

ArticleYear
Cimetidine reduces alveolar bone loss in induced periodontitis in rat molars.
    Journal of periodontology, 2014, Volume: 85, Issue:8

    Topics: Acid Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Cimetidine; Coloring Agents; Connec

2014
Acetaminophen hepatotoxicity: current management.
    The Mount Sinai journal of medicine, New York, 2009, Volume: 76, Issue:1

    Topics: Acetaminophen; Acetylcysteine; Antidotes; Charcoal; Chemical and Drug Induced Liver Injury; Cimetidi

2009
Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.
    British journal of cancer, 2012, Aug-07, Volume: 107, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Cimetidine; Colorectal Neoplasms; Cyclophosphamide; Diclofenac; Di

2012
Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:11

    Topics: Abietanes; Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents;

2002
Psoriasis in an HIV-positive patient treated with cimetidine.
    Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:1

    Topics: Adult; Cimetidine; Disease Progression; Follow-Up Studies; HIV Infections; Humans; Male; Psoriasis;

1995